Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Assets: 2016-2019

Historic Assets for Monopar Therapeutics (MNPR) over the last 4 years, with Dec 2019 value amounting to $13.4 million.

  • Monopar Therapeutics' Assets rose 255.40% to $18.2 million in Q3 2020 from the same period last year, while for Sep 2020 it was $18.2 million, marking a year-over-year increase of 255.40%. This contributed to the annual value of $13.4 million for FY2019, which is 82.46% up from last year.
  • Latest data reveals that Monopar Therapeutics reported Assets of $13.4 million as of FY2019, which was up 82.46% from $7.3 million recorded in FY2018.
  • Monopar Therapeutics' 5-year Assets high stood at $13.4 million for FY2019, and its period low was $2.9 million during FY2016.
  • Moreover, its 3-year median value for Assets was $9.9 million (2017), whereas its average is $10.2 million.
  • Its Assets has fluctuated over the past 5 years, first surged by 242.98% in 2017, then fell by 26.31% in 2018.
  • Over the past 4 years, Monopar Therapeutics' Assets (Yearly) stood at $2.9 million in 2016, then surged by 242.98% to $9.9 million in 2017, then fell by 26.31% to $7.3 million in 2018, then spiked by 82.46% to $13.4 million in 2019.